LumiraDX slips on bigger-than-expected loss

LumiraDx

24/08/2023 15:01

** Diagnostics company LumiraDx's  LMDX.O  shares down 4.4%
at 39 cents  
    ** Co reports Q2 loss of 16 cents per share wider than 
analysts' est. of loss of 14 cents per share - Refinitiv
    ** LMDX's Q2 revenue at $21 mln vs $44.7 million last year 
    ** Co also reports quarterly revenue of $9.2 mln from
non-COVID products , about 44% of total revenues
    ** Up to last close, stock down ~55% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))